Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y4KE
|
|||
| Former ID |
DAP000965
|
|||
| Drug Name |
Collagenase
|
|||
| Indication | Dermal ulcers [ICD-11: 1A36; ICD-10: A06, A06.9] | Approved | [1], [2] | |
| Skin burns [ICD-11: ME65.0] | Approved | [1], [2] | ||
| Therapeutic Class |
Antiulcer Agents
|
|||
| SuperDrug ATC ID |
D03BA02
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Collagen (CO) | Target Info | Breaker | [3], [4] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. | |||
| REF 3 | Contact dermatitis with clostridiopeptidase A contained in Noruxol ointment. Contact Dermatitis. 2007 Jun;56(6):361-2. | |||
| REF 4 | Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):646-53. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.